Reapplix (private company)

See something wrong or missing? Let us know
Offices:Birkerod
Industry:Biotech
Business model:B2B

Reapplix ApS, a research and development company, identifies blood-derived proteins that improve wound healing, isolates them, and reapplies them to patients with chronic wounds. The company was founded in 2008 and is based in Birkerod, Denmark.

Investors: we tracked 6 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 29.33M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Reapplix

Name Criteria
Denmark Draupnir Bio
50%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 10M+ USD
Denmark Galecto Biotech
50%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds, Seed Capital
  • Total raised in a similar range: 10M+ USD
Denmark IO Biotech
50%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 10M+ USD
Denmark MinervaX
50%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds, Seed Capital
  • Total raised in a similar range: 10M+ USD
Denmark NMD Pharma
50%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 10M+ USD
Denmark AFYX Therapeutics
50%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 10M+ USD
Denmark Chromologics
40%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Vækstfonden, Novo Seeds
Denmark Fidabio
40%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Vækstfonden
Denmark Freesense
40%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Vækstfonden
Sweden Glionova
40%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
Top